Skip to Main Content

Good morning, everyone, and welcome to another working week. We hope the extended respite — at least on this side of the pond — was relaxing and refreshing because the crushing routine of meetings, deadlines, texts, and conference calls has, predictably, returned. Summer is effectively over. But what can you do? The world keeps spinning and since the pause button is not an option, please join us for a delicious cup of stimulation — we are reaching for hazelnut creme today. Meanwhile, here are some tidbits to help you catch up. Hope your re-entry is manageable and do keep us in mind if something fascinating pops up. …

A proposed deal for Purdue Pharma to resolve more than 2,000 lawsuits over its role in the opioid crisis is facing pushback from a vocal group of state attorneys general who say it fails to bring in enough cash to satisfy their demands, according to The Wall Street Journal. Among the concerns is a reliance on future drug sales, how much money will be guaranteed, and contributions from the Sackler family, which owns the drug maker.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!